Table 4.
Variable | Haz. Ratio | p > z | 95% Conf. Interval | |
---|---|---|---|---|
Age at diagnosis | 1.02 | 0.02 1 | 1.00−1.04 | |
1.01 2 | 0.2 | 0.99−1.04 | ||
Gender | 0.62 | 0.1 | 0.33−1.14 | |
0.65 | 0.2 | 0.32−1.33 | ||
Altitude of Residence | 1.00 | 0.004 | 1.00−1.00 | |
1.00 | 0.03 | 1.00−1.00 | ||
Anatomical Site | 1.13 | 0.3 | 0.90−1.40 | |
1.01 | 0.9 | 0.77−1.32 | ||
Geographic area | 1.13 | 0.5 | 0.69−1.87 | |
1.13 | 0.8 | 0.42−3.01 | ||
TRPM1 | 0.76 | 0.5 | 0.36−1.61 | |
0.72 | 0.5 | 0.29−1.80 | ||
TYRP1 | 2.43 | 0.01 | 1.24−4.77 | |
2.51 | 0.02 | 1.15−5.48 | ||
PDL1 (CD274) | 0.71 | 0.3 | 0.37−1.35 | |
0.49 | 0.06 | 0.23−1.01 | ||
CD2 | 0.75 | 0.4 | 0.39−1.42 | |
0.94 | 0.9 | 0.46−1.93 | ||
MITF | 0.51 | 0.04 | 0.27−0.97 | |
0.98 | 0.9 | 0.44−2.19 | ||
HIF1A | 1.15 | 0.6 | 0.66−2.00 | |
1.39 | 0.4 | 0.69−2.75 | ||
miR-150-5p | 0.96 | 0.9 | 0.48−1.93 | |
0.62 | 0.3 | 0.27−1.42 | ||
miR-155-5p | 0.95 | 0.9 | 0.50−1.79 | |
0.86 | 0.7 | 0.41−1.80 | ||
miR-204-5p | 0.87 | 0.7 | 0.48−1.59 | |
1.08 | 0.8 | 0.53−2.19 | ||
miR-211-5p | 0.99 | 1 | 0.44−2.25 | |
0.58 | 0.3 | 0.21−1.60 | ||
Mutational Status | 1.98 | <0.001 | 1.40−2.25 | |
1.55 | 0.04 | 1.01−2.39 | ||
Stage at diagnosis | II | 0.67 | 0.4 | 0.25−1.81 |
0.95 | 0.9 | 0.27−3.31 | ||
III | 1.38 | 0.5 | 0.49−3.94 | |
1.87 | 0.4 | 0.48−7.32 | ||
IV | 9.89 | <0.001 | 2.76−35.5 | |
11.1 | 0.008 | 1.88−65.8 | ||
Ulceration | 1.3 | 0.4 | 0.72−2.34 | |
1.5 | 0.3 | 0.73−2.99 | ||
phtest p = 0.3 | ||||
phtest p = 0.1 |
1: Underlined p highlights statistical significance; 2: In italics are reported the values of the Cox regression by exclusion of patients from Innsbruck and its land.